Boston Scientific (UK) Insiders
0HOY Stock | 90.59 0.59 0.65% |
Boston Scientific employs about 48 K people. The company is managed by 16 executives with a total tenure of roughly 112000 years, averaging almost 7000.0 years of service per executive, having 3000.0 employees per reported executive. Breaking down Boston Scientific's management performance can provide insight into the firm performance.
Michael Mahoney Chairman President Chairman |
Boston |
Boston Scientific Management Team Effectiveness
The company has return on total asset (ROA) of 0.049 % which means that it generated a profit of $0.049 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0892 %, meaning that it generated $0.0892 on every $100 dollars invested by stockholders. Boston Scientific's management efficiency ratios could be used to measure how well Boston Scientific manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Boston Scientific's Non Currrent Assets Other are comparatively stable compared to the past year. Other Assets is likely to gain to about 5.5 B in 2024, whereas Non Current Assets Total are likely to drop slightly above 21.4 B in 2024.Common Stock Shares Outstanding is likely to gain to about 1.5 B in 2024. Net Income Applicable To Common Shares is likely to gain to about 1.1 B in 2024
Boston Scientific Workforce Comparison
Boston Scientific Corp is number one stock in number of employees category among its peers. The total workforce of Industrials industry is presently estimated at about 57,396. Boston Scientific totals roughly 48,000 in number of employees claiming about 84% of equities under Industrials industry.
The company has Profit Margin (PM) of 0.11 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.17 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.17. Boston Scientific Corp Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Boston Scientific Corp Price Series Summation is a cross summation of Boston Scientific price series and its benchmark/peer.
Boston Scientific Notable Stakeholders
A Boston Scientific stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Boston Scientific often face trade-offs trying to please all of them. Boston Scientific's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Boston Scientific's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Michael Mahoney | President Chairman | Profile | |
Daniel CPA | Executive CFO | Profile | |
Daniel Brennan | Executive CFO | Profile | |
David Roux | Independent Director | Profile | |
Catherine Jennings | VP Interventions | Profile | |
Emily Woodworth | Global VP | Profile | |
Vance Brown | General VP | Profile | |
Jodi Eddy | Senior Officer | Profile | |
John Sorenson | Executive Operations | Profile | |
Arthur Butcher | Executive Pacific | Profile | |
Joseph Fitzgerald | Executive Cardiology | Profile | |
Mary Moynihan | Senior Officer | Profile | |
Jeffrey Mirviss | Executive Interventions | Profile | |
Jonathan Monson | Senior Relations | Profile | |
Susan Lisa | Vice Relations | Profile | |
Jeffrey MBA | Executive Interventions | Profile |
About Boston Scientific Management Performance
The success or failure of an entity such as Boston Scientific Corp often depends on how effective the management is. Boston Scientific management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Boston management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Boston management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Boston Scientific is entity of United Kingdom. It is traded as Stock on LSE exchange.
Please note, the imprecision that can be found in Boston Scientific's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Boston Scientific Corp. Check Boston Scientific's Beneish M Score to see the likelihood of Boston Scientific's management manipulating its earnings.
Boston Scientific Workforce Analysis
Traditionally, organizations such as Boston Scientific use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Boston Scientific within its industry.Boston Scientific Manpower Efficiency
Return on Boston Scientific Manpower
Revenue Per Employee | 296.7K | |
Revenue Per Executive | 890M | |
Net Income Per Employee | 33.2K | |
Net Income Per Executive | 99.5M |
Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.